查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1509631

2024 年内分泌检测全球市场报告

Endocrine Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

内分泌检测市场规模预计在未来几年将强劲成长。 2028年，这一数字将以9.6%的复合年增长率成长至36.7亿美元。预测期内的预期增长是由多种因素推动的，包括内分泌疾病患病率的增加、国防开支的增加、人口老龄化、意识和早期诊断工作的提高以及对内分泌健康的整体认识的提高。认为是由多种因素造成的。预测期内预期的主要趋势包括生物标记检测技术的进步、体学技术的整合、利用人工智慧和机器学习进行诊断、强调品质保证和标准化措施、合作研究工作和翻译这包括强调民族医学接近。

糖尿病盛行率的上升趋势预计将在短期内推动内分泌检测市场的成长。糖尿病的特征是血糖值升高，由于多种因素，包括不健康的饮食模式、久坐的生活方式、遗传倾向和衰老，其发病率正在上升。内分泌检测在糖尿病管理中发挥重要作用，包括血红蛋白 A1c、空腹血糖和 C胜肽检测等检测，以诊断病情、监测血糖浓度并评估胰岛素的产生和敏感性。例如，国际糖尿病联盟2021年发布的资料显示，全球约有5.37亿成年人（20岁至79岁）患有糖尿病。据预测，2030年这数字将进一步增加至6.43亿人，2045年将达到7.83亿人。因此，糖尿病盛行率的快速上升刺激了内分泌检测市场的需求。

内分泌检测市场的主要参与企业正在专注于开发就地检验解决方案，以提高诊断内分泌疾病的可及性和效率。就地检验可以快速获得结果，并有助于快速诊断和管理出现呼吸急促和疲劳等症状的患者的心臟衰竭等疾病。例如，2024 年 4 月，瑞士製药公司罗氏控股公司在印度推出了照护现场NT-proBNP 检测。该测试专门用于筛检心臟衰竭（HF）等心血管疾病风险的糖尿病患者，促进早期发现和早期疗育。该测试使临床医生能够快速识别高风险 T2D 患者并及时启动治疗，最终改善结果和患者福祉。

目录

第一章执行概述

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球内分泌检测市场：驱动因素与抑制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球内分泌检测市场表现：规模与成长，2018-2023
  • 全球内分泌检测市场预测：规模与成长，2023-2028、2033

第六章 市场细分

  • 全球内分泌检测市场：依检测类型分類的表现与预测，2018-2023年、2023-2028年、2033年
  • 雌二醇（E2）测试
  • 滤泡刺激素(FSH) 测试
  • 人类绒毛膜促性腺激素分泌(hCG) 荷尔蒙测试
  • 黄体激素（LH）测试
  • 硫酸去氢表雄酮（DHEAS）测试
  • 黄体酮测试
  • 睪酮测试
  • 甲状腺刺激素（TSH）测试
  • 催乳素测试
  • 其他的
  • 全球内分泌检测市场：依技术、效能和预测划分，2018-2023年、2023-2028年、2033年
  • 串联式质谱质谱法
  • 免疫检测
  • 单株和多株抗体技术
  • 感测器技术
  • 临床化学
  • 其他的
  • 全球内分泌检测市场：按最终用户、效能和预测，2018-2023、2023-2028、2033
  • 医院
  • 临床实验室
  • 诊断中心
  • 其他的

第 7 章 区域/国家分析

  • 全球内分泌检测市场：按地区、绩效及预测，2018-2023年、2023-2028年、2033年
  • 全球内分泌检测市场：依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 内分泌检测市场：竞争格局
  • 内分泌检测市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Roche Holding
    • Siemens Healthineers
    • Quest Diagnostics

第31章 其他大型创新企业

  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • BioMerieux SA
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • Qiagen NV
  • Ortho Clinical Diagnostics
  • Kronus Inc.
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Inova Diagnostics Inc.
  • Sekisui Diagnostics LLC
  • Mercodia AB
  • ZEUS Scientific Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r18128

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.33 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed in the historical period can be attributed to several key factors, including the discovery of hormones and endocrine pathways, the standardization of diagnostic tests, the implementation of public health initiatives, and the increased advocacy and empowerment of patients.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the forecast period can be attributed to various factors, including the growing prevalence of endocrine disorders, heightened defense spending, an aging population, increased awareness and early diagnosis initiatives, and heightened overall awareness regarding endocrine health. Key trends expected in the forecast period encompass advancements in biomarker detection techniques, the integration of omics technologies, the utilization of artificial intelligence and machine learning for diagnostic purposes, a focus on quality assurance and standardization measures, and an emphasis on collaborative research efforts and translational medicine approaches.

The upward trend in diabetes prevalence is anticipated to drive the growth of the endocrine testing market in the foreseeable future. Diabetes, a condition characterized by elevated blood sugar levels, is on the rise due to various factors such as unhealthy dietary patterns, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine testing plays a crucial role in diabetes management, encompassing tests such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests to diagnose the condition, monitor glucose levels, and evaluate insulin production and sensitivity. For instance, data from the International Diabetes Federation in 2021 revealed that approximately 537 million adults (aged 20-79 years) globally were living with diabetes. Projections indicate a further increase to 643 million by 2030 and 783 million by 2045. Consequently, the surge in diabetes prevalence is stimulating demand within the endocrine testing market.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
  • 2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal & Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
  • 3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Endocrine Testing Market Size and Growth

  • 5.1. Global Endocrine Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Endocrine Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Endocrine Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Endocrine Testing Market Segmentation

  • 6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Hormone Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone Sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Other Types
  • 6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal And Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Other Technologies
  • 6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Other End-Users

7. Endocrine Testing Market Regional And Country Analysis

  • 7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Endocrine Testing Market

  • 8.1. Asia-Pacific Endocrine Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Endocrine Testing Market

  • 9.1. China Endocrine Testing Market Overview
  • 9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Endocrine Testing Market

  • 10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Endocrine Testing Market

  • 11.1. Japan Endocrine Testing Market Overview
  • 11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Endocrine Testing Market

  • 12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Endocrine Testing Market

  • 13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Endocrine Testing Market

  • 14.1. South Korea Endocrine Testing Market Overview
  • 14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Endocrine Testing Market

  • 15.1. Western Europe Endocrine Testing Market Overview
  • 15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Endocrine Testing Market

  • 16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Endocrine Testing Market

  • 17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Endocrine Testing Market

  • 18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Endocrine Testing Market

  • 19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Endocrine Testing Market

  • 20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Endocrine Testing Market

  • 21.1. Eastern Europe Endocrine Testing Market Overview
  • 21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Endocrine Testing Market

  • 22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Endocrine Testing Market

  • 23.1. North America Endocrine Testing Market Overview
  • 23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Endocrine Testing Market

  • 24.1. USA Endocrine Testing Market Overview
  • 24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Endocrine Testing Market

  • 25.1. Canada Endocrine Testing Market Overview
  • 25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Endocrine Testing Market

  • 26.1. South America Endocrine Testing Market Overview
  • 26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Endocrine Testing Market

  • 27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Endocrine Testing Market

  • 28.1. Middle East Endocrine Testing Market Overview
  • 28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Endocrine Testing Market

  • 29.1. Africa Endocrine Testing Market Overview
  • 29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Testing Market Competitive Landscape
  • 30.2. Endocrine Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Quest Diagnostics
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Endocrine Testing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. PerkinElmer Inc.
  • 31.3. BioMerieux SA
  • 31.4. Beckman Coulter Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. SD Biosensor Inc.
  • 31.7. Qiagen N.V.
  • 31.8. Ortho Clinical Diagnostics
  • 31.9. Kronus Inc.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. Fujirebio Diagnostics Inc.
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Sekisui Diagnostics LLC
  • 31.14. Mercodia AB
  • 31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking

33. Global Endocrine Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Endocrine Testing Market

35. Endocrine Testing Market Future Outlook and Potential Analysis

  • 35.1 Endocrine Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer